FDA Flags 2,200+ Sponsors Over Missing Trial Results Recent signals from the US FDA suggest regulators are preparing a more tailored approach for CAR-T therapies in autoimmune diseases. Read more
A Breakthrough in One of the Deadliest Cancers? What Daraxonrasib Really Changes Recent signals from the US FDA suggest regulators are preparing a more tailored approach for CAR-T therapies in autoimmune diseases. Read more
Clinical Research Focus. 51st Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of January 2026. Read more
FDA Signals Shift in Regulatory Approach to Autoimmune CAR-T Recent signals from the US FDA suggest regulators are preparing a more tailored approach for CAR-T therapies in autoimmune diseases. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us